DNA vaccines for biodefence.

[1]  Donna J. Freeman,et al.  Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen. , 2004, Vaccine.

[2]  K. Brown,et al.  Genetic Vaccines and Therapy , 2003 .

[3]  B. Ivins,et al.  Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus. , 2003, Vaccine.

[4]  R. Titball,et al.  Vaccine development for potential bioterrorism agents. , 2003, Current drug targets. Infectious disorders.

[5]  D. Olson,et al.  Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  A. Bennett,et al.  DNA vaccination protects against botulinum neurotoxin type F. , 2003, Vaccine.

[7]  J. Whitton,et al.  "Translocatory proteins" and "protein transduction domains": a critical analysis of their biological effects and the underlying mechanisms. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[8]  M. Johansson,et al.  Cell surface adherence and endocytosis of protein transduction domains. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  N. Restifo,et al.  DNA vaccines and apoptosis: to kill or not to kill? , 2003, The Journal of clinical investigation.

[10]  Tae Woo Kim,et al.  Enhancing DNA vaccine potency by coadministration of DNA encoding antiapoptotic proteins. , 2003, The Journal of clinical investigation.

[11]  H. Vordermeier,et al.  Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting. , 2003, Veterinary microbiology.

[12]  W. Britton,et al.  The combination of plasmid interleukin‐12 with a single DNA vaccine is more effective than Mycobacterium bovis (bacille Calmette–Guèrin) in protecting against systemic Mycobacterim avium infection , 2003, Immunology.

[13]  D. Webster,et al.  Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans , 2003, Nature Medicine.

[14]  J. Ulmer,et al.  Plasmid DNA encoding human carcinoembryonic antigen (CEA) adsorbed onto cationic microparticles induces protective immunity against colon cancer in CEA-transgenic mice. , 2003, Vaccine.

[15]  J. Ulmer,et al.  Technical and regulatory hurdles for DNA vaccines. , 2003, International journal for parasitology.

[16]  A. Venuti,et al.  DNA vaccines against HPV-16 E7-expressing tumour cells. , 2003, Anticancer research.

[17]  E. Thompson,et al.  Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates , 2003, Virology.

[18]  A. Shafferman,et al.  Effective Protective Immunity to Yersinia pestis Infection Conferred by DNA Vaccine Coding for Derivatives of the F1 Capsular Antigen , 2003, Infection and Immunity.

[19]  K. Brown,et al.  Salmonella vaccines for use in humans: present and future perspectives. , 2002, FEMS microbiology reviews.

[20]  T. Mitchell,et al.  Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways1 , 2002, The Journal of Immunology.

[21]  D. Fuller,et al.  Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma. , 2002, Current opinion in molecular therapeutics.

[22]  A. Hill,et al.  Role of transfection in the priming of cytotoxic T-cells by DNA-mediated immunization. , 2002, Vaccine.

[23]  W. Britton,et al.  Comparative affects of plasmid‐encoded interleukin 12 and interleukin 18 on the protective efficacy of DNA vaccination against Mycobacterium tuberculosis , 2002, Immunology and cell biology.

[24]  G. Altman.  Tularemia. A pathogen in nature and a biological weapon. , 2002, AAOHN journal : official journal of the American Association of Occupational Health Nurses.

[25]  J. Levy,et al.  Enhancement of antibody responses to an HIV-2 DNA envelope vaccine using an expression vector containing a constitutive transport element. , 2002, DNA and cell biology.

[26]  L. Baillie,et al.  Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague. , 2002, Vaccine.

[27]  Vincent W. Bramwell,et al.  Liposome/DNA complexes coated with biodegradable PLA improve immune responses to plasmid encoding hepatitis B surface antigen , 2002, Immunology.

[28]  Y. Singh,et al.  Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin. , 2002, Vaccine.

[29]  G. Lewis,et al.  Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1. , 2002, Vaccine.

[30]  T. Wu,et al.  Improving DNA Vaccine Potency by Linking Marek's Disease Virus Type 1 VP22 to an Antigen , 2002, Journal of Virology.

[31]  H. Zentgraf,et al.  Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination. , 2002, Virology.

[32]  M. Johansson,et al.  Positively charged DNA-binding proteins cause apparent cell membrane translocation. , 2002, Biochemical and biophysical research communications.

[33]  L. Lunsford,et al.  Protective immune responses elicited in mice by immunization with formulations of poly(lactide-co-glycolide) microparticles. , 2002, Vaccine.

[34]  G. Delogu,et al.  DNA Vaccine Combinations Expressing Either Tissue Plasminogen Activator Signal Sequence Fusion Proteins or Ubiquitin-Conjugated Antigens Induce Sustained Protective Immunity in a Mouse Model of Pulmonary Tuberculosis , 2002, Infection and Immunity.

[35]  S. Hoffman,et al.  Codon Optimization of Gene Fragments EncodingPlasmodium falciparum Merzoite Proteins Enhances DNA Vaccine Protein Expression and Immunogenicity in Mice , 2001, Infection and Immunity.

[36]  D. Zhu,et al.  DNA fusion vaccines against B-cell tumors. , 2001, Trends in molecular medicine.

[37]  A. Fauci,et al.  Bioterrorism: A clear and present danger , 2001, Nature Medicine.

[38]  G. Khuller,et al.  DNA vaccines: Future strategies and relevance to intracellular pathogens , 2001, Immunology and cell biology.

[39]  M. Graf,et al.  Multiple Effects of Codon Usage Optimization on Expression and Immunogenicity of DNA Candidate Vaccines Encoding the Human Immunodeficiency Virus Type 1 Gag Protein , 2001, Journal of Virology.

[40]  J. Whitton,et al.  Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine. , 2001, Human gene therapy.

[41]  J. Ulmer,et al.  Induction of Potent Immune Responses by Cationic Microparticles with Adsorbed Human Immunodeficiency Virus DNA Vaccines , 2001, Journal of Virology.

[42]  C Crimi,et al.  Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. , 2001, Vaccine.

[43]  A. Suhrbier,et al.  Cytotoxic T cell polyepitope vaccines delivered by ISCOMs. , 2001, Vaccine.

[44]  I. Hashimoto,et al.  Keratinocyte gene therapy: inducible promoters and in vivo control of transgene expression , 2001, Clinical and experimental dermatology.

[45]  M. Johansson,et al.  Is VP22 nuclear homing an artifact? , 2001, Nature Biotechnology.

[46]  J. Rice,et al.  DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines1 , 2001, The Journal of Immunology.

[47]  N. Walters,et al.  M cell-targeted DNA vaccination , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[48]  T. Mayumi,et al.  Optimization of transcriptional regulatory elements for constructing plasmid vectors. , 2001, Gene.

[49]  G. Splitter,et al.  A genetic immunization adjuvant system based on BVP22-antigen fusion. , 2001, Human gene therapy.

[50]  S. Leppla,et al.  Protection against Anthrax Lethal Toxin Challenge by Genetic Immunization with a Plasmid Encoding the Lethal Factor Protein , 2001, Infection and Immunity.

[51]  J. Sotos.  Botulinum toxin in biowarfare. , 2001, JAMA.

[52]  J. Reimann,et al.  Modulation of Gene-Gun-Mediated Th2 Immunity to Hepatitis B Surface Antigen by Bacterial CpG Motifs or IL-12 , 2001, Intervirology.

[53]  H. Robinson,et al.  Apoptosis-mediated enhancement of DNA-raised immune responses by mutant caspases , 2001, Nature Biotechnology.

[54]  L. Faccioli,et al.  Comparison of different delivery systems of vaccination for the induction of protection against tuberculosis in mice. , 2001, Vaccine.

[55]  T. Wu,et al.  Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. , 2001, Cancer research.

[56]  S. Chen,et al.  Targeting dendritic cells to enhance DNA vaccine potency. , 2001, Cancer research.

[57]  T. Wu,et al.  Improving Vaccine Potency Through Intercellular Spreading and Enhanced MHC Class I Presentation of Antigen1 , 2001, The Journal of Immunology.

[58]  J. Wesche,et al.  Ability of the Tat basic domain and VP22 to mediate cell binding, but not membrane translocation of the diphtheria toxin A-fragment. , 2001, Biochemistry.

[59]  P. Pescher,et al.  Mixed immune response induced in rodents by two naked DNA genes coding for mycobacterial glycosylated proteins. , 2001, Vaccine.

[60]  D. McDonald,et al.  Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells , 2000, Gene Therapy.

[61]  N. Fairweather,et al.  Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. , 2000, Vaccine.

[62]  I. Hirono,et al.  Assessment of DNA vaccine potential for juvenile Japanese flounder Paralichthys olivaceus, through the introduction of reporter genes by particle bombardment and histopathology. , 2000, Vaccine.

[63]  S. Hoffman,et al.  Plasmid Vaccine Expressing Granulocyte-Macrophage Colony-Stimulating Factor Attracts Infiltrates Including Immature Dendritic Cells into Injected Muscles1 , 2000, The Journal of Immunology.

[64]  S. Schultz-Cherry,et al.  The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model. , 2000, Avian diseases.

[65]  V. Zurawski,et al.  Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine. , 2000, Biochimica et biophysica acta.

[66]  D. Prazeres,et al.  Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. , 2000, Trends in biotechnology.

[67]  J. Kim,et al.  Targeted antigen delivery to antigen–presenting cells including dendritic cells by engineered Fas-mediated apoptosis , 2000, Nature Biotechnology.

[68]  A. Villaverde,et al.  Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression. , 2000, Biotechnology and bioengineering.

[69]  L. Brown,et al.  A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Arifa S. Khan,et al.  Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina. , 2000, Vaccine.

[71]  J. Reimann,et al.  Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control. , 2000, Vaccine.

[72]  J. Gebhard,et al.  DNA immunization utilizing a herpes simplex virus type 2 myogenic DNA vaccine protects mice from mortality and prevents genital herpes. , 2000, Vaccine.

[73]  Y. Koide,et al.  Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses. , 2000, Vaccine.

[74]  J. Middlebrook,et al.  Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A. , 2000, Vaccine.

[75]  C. Schmaljohn,et al.  DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. , 2000, Virology.

[76]  Manmohan J. Singh,et al.  Cationic microparticles: A potent delivery system for DNA vaccines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Gunther Hartmann,et al.  Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1 , 2000, The Journal of Immunology.

[78]  C. Mandl,et al.  A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. , 1999, Journal of immunology.

[79]  N. Restifo,et al.  DNA and RNA-based vaccines: principles, progress and prospects. , 1999, Vaccine.

[80]  R. Kurman,et al.  Targeting human papillomavirus type 16 E7 to the endosomal/lysosomal compartment enhances the antitumor immunity of DNA vaccines against murine human papillomavirus type 16 E7-expressing tumors. , 1999, Human gene therapy.

[81]  A. Bennett,et al.  Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus. , 1999, Vaccine.

[82]  M. Tao,et al.  Modulation of immune responses to DNA vaccines by codelivery of cytokine genes. , 1999, Journal of the Formosan Medical Association = Taiwan yi zhi.

[83]  F. Elgh,et al.  Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters. , 1999, Virology.

[84]  T. Horii,et al.  Immune Responses Induced by Gene Gun or Intramuscular Injection of DNA Vaccines That Express Immunogenic Regions of the Serine Repeat Antigen from Plasmodium falciparum , 1999, Infection and Immunity.

[85]  P. Courvalin,et al.  Bacteria as gene delivery vectors for mammalian cells. , 1999, Current opinion in biotechnology.

[86]  H. Wigzell,et al.  Enhancement of antibody responses by DNA immunization using expression vectors mediating efficient antigen secretion. , 1999, Journal of immunological methods.

[87]  N. Fairweather,et al.  Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines. , 1999, Vaccine.

[88]  P. Tiollais,et al.  Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. , 1999, Virology.

[89]  M. Levine,et al.  Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses. , 1999, Clinical immunology.

[90]  Haddad,et al.  Characterization of Antibody Responses to a Plasmodium falciparum Blood‐Stage Antigen Induced by a DNA Prime/Protein Boost Immunization Protocol , 1999, Scandinavian journal of immunology.

[91]  R. Purcell,et al.  Route and Method of Delivery of DNA Vaccine Influence Immune Responses in Mice and Non-Human Primates , 1999, Molecular medicine.

[92]  L. Vinner,et al.  Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons. , 1999, Vaccine.

[93]  R. Titball,et al.  An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model , 1999, Clinical and experimental immunology.

[94]  R. Wittek,et al.  Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. , 1999, Virology.

[95]  S. Leppla,et al.  Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen. , 1999, Vaccine.

[96]  Y. Koide,et al.  Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. , 1998, Journal of immunology.

[97]  T. Hamblin,et al.  DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma , 1998, Nature Medicine.

[98]  A. Friedlander,et al.  Weak anamnestic responses of inbred mice to Yersinia F1 genetic vaccine are overcome by boosting with F1 polypeptide while outbred mice remain nonresponsive. , 1998, Journal of immunology.

[99]  R. Hall,et al.  DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. , 1998, Virology.

[100]  A. Krieg,et al.  Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. , 1998, Antisense & nucleic acid drug development.

[101]  Wang,et al.  Targeting immune response induction with cochleate and liposome-based vaccines. , 1998, Advanced drug delivery reviews.

[102]  H. Greenberg,et al.  Protective Immunity Induced by Oral Immunization with a Rotavirus DNA Vaccine Encapsulated in Microparticles , 1998, Journal of Virology.

[103]  P. Jahrling,et al.  DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. , 1998, Virology.

[104]  L. Baillie,et al.  Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers. , 1998, Vaccine.

[105]  P. Mason,et al.  Antibody Response in Mice Inoculated with DNA Expressing Foot-and-Mouth Disease Virus Capsid Proteins , 1998, Journal of Virology.

[106]  Marion Becker,et al.  Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara , 1998, Nature Medicine.

[107]  J. Brady,et al.  Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction , 1998, Nature.

[108]  J. D. Malone,et al.  Anthrax as a potential biological warfare agent. , 1998, Archives of internal medicine.

[109]  J. Haas,et al.  Increased Immune Response Elicited by DNA Vaccination with a Synthetic gp120 Sequence with Optimized Codon Usage , 1998, Journal of Virology.

[110]  W. Goebel,et al.  Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes , 1998, Nature Biotechnology.

[111]  Mcbride,et al.  Production and purification of recombinant protective antigen and protective efficacy against Bacillusanthracis , 1998, Letters in applied microbiology.

[112]  K. Timmis,et al.  Oral Somatic Transgene Vaccination Using Attenuated S. typhimurium , 1997, Cell.

[113]  A. Lew,et al.  Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization. , 1997, International immunology.

[114]  H. Davis,et al.  Plasmid DNA expression systems for the purpose of immunization. , 1997, Current opinion in biotechnology.

[115]  Y. Sung,et al.  Comparison of various expression plasmids for the induction of immune response by DNA immunization. , 1997, Molecules and cells.

[116]  J. Haynes,et al.  Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization. , 1997, Vaccine.

[117]  J. Sadoff,et al.  Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. , 1997, Vaccine.

[118]  L. Babiuk,et al.  Polynucleotide vaccines in animals: enhancing and modulating responses. , 1997, Vaccine.

[119]  S. Johnston,et al.  Biological features of genetic immunization. , 1997, Vaccine.

[120]  D. Klinman,et al.  Contribution of CpG motifs to the immunogenicity of DNA vaccines. , 1997, Journal of immunology.

[121]  R. Siliciano,et al.  Targeting of HIV-1 Antigens for Rapid Intracellular Degradation Enhances Cytotoxic T Lymphocyte (CTL) Recognition and the Induction of De Novo CTL Responses In Vivo After Immunization , 1997, The Journal of experimental medicine.

[122]  U. Spengler,et al.  Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization. , 1997, DNA and cell biology.

[123]  G. Gregoriadis,et al.  Liposome‐mediated DNA vaccination , 1997, FEBS letters.

[124]  G. Elliott,et al.  Intercellular Trafficking and Protein Delivery by a Herpesvirus Structural Protein , 1997, Cell.

[125]  S. Welkos,et al.  Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge , 1996, Infection and immunity.

[126]  R. Bartlett,et al.  Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: comparison of human creatine kinase and CMV promoter expression levels in vivo. , 1996, Cell transplantation.

[127]  S. Beaucage,et al.  CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[128]  Kathleen R. Cho,et al.  Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[129]  E. Griffiths.  Assuring the Safety and Efficacy of DNA Vaccines , 1995, Annals of the New York Academy of Sciences.

[130]  J. Sadoff,et al.  Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization , 1995, Science.

[131]  R. Titball,et al.  Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague , 1995, Infection and immunity.

[132]  M. Hashida,et al.  The Fate of Plasmid DNA After Intravenous Injection in Mice: Involvement of Scavenger Receptors in Its Hepatic Uptake , 1995, Pharmaceutical Research.

[133]  G. Bishop,et al.  CpG motifs in bacterial DNA trigger direct B-cell activation , 1995, Nature.

[134]  M. Yokoyama,et al.  DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection , 1995, Journal of virology.

[135]  R. Webster,et al.  Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. , 1994, Vaccine.

[136]  A. Rundell,et al.  Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. , 1993, Human gene therapy.

[137]  N. Yang,et al.  In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[138]  E. Kuramoto,et al.  DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth , 1992, Microbiology and immunology.

[139]  D. Tang,et al.  Genetic immunization is a simple method for eliciting an immune response , 1992, Nature.

[140]  N. Haigwood,et al.  Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. , 1991, Nucleic acids research.

[141]  M. Kozak,et al.  At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. , 1987, Journal of molecular biology.

[142]  K. Venugopal,et al.  Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus , 2005, Archives of Virology.

[143]  R. Whitley,et al.  Smallpox: a potential agent of bioterrorism. , 2003, Antiviral research.

[144]  M. Plebanski,et al.  DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy. , 2000, Developments in biologicals.

[145]  R. K. Bright,et al.  DNA cancer vaccination strategies target SV40 large tumour antigen in a murine experimental metastasis model. , 2000, Developments in biologicals.

[146]  W. W. Nichols,et al.  Plasmid DNA vaccines: assay for integration into host genomic DNA. , 2000, Developments in biologicals.

[147]  S. Gurunathan,et al.  DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.

[148]  S. S. Tang,et al.  DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice. , 2000, Journal of biomedical science.

[149]  K. Okuda,et al.  DNA-Plasmids of HIV-1 Induce Systemic and Mucosal Immune Responses , 1999, Biological chemistry.

[150]  J. Clegg,et al.  Oral delivery of micro-encapsulated DNA vaccines. , 1998, Developments in biological standardization.

[151]  A. Krieg,et al.  The role of CpG dinucleotides in DNA vaccines. , 1998, Trends in microbiology.

[152]  K. Porter,et al.  Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses , 1998, Archives of Virology.

[153]  T. Ikemura.  Codon usage and tRNA content in unicellular and multicellular organisms. , 1985, Molecular biology and evolution.

[154]  M. Moody,et al.  An unusual strain of Pasteurella pestis isolated from a fatal human case of plague. , 1960, Bulletin of the World Health Organization.